- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/712 - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
Patent holdings for IPC class A61K 31/712
Total number of patents in this class: 1566
10-year publication summary
|
66
|
90
|
101
|
104
|
121
|
159
|
148
|
153
|
164
|
60
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 776 |
115 |
| Alnylam Pharmaceuticals, Inc. | 1066 |
49 |
| F. Hoffmann-La Roche AG | 7958 |
30 |
| Hoffmann-La Roche Inc. | 3060 |
30 |
| Osaka University | 3143 |
26 |
| Roche Innovation Center Copenhagen A/S | 148 |
25 |
| Sarepta Therapeutics, Inc. | 353 |
24 |
| University of Massachusetts | 2130 |
23 |
| Nippon Shinyaku Co., Ltd. | 297 |
22 |
| Wave Life Sciences Ltd. | 151 |
22 |
| Avidity Biosciences, Inc. | 110 |
18 |
| Isis Pharmaceuticals, Inc. | 255 |
17 |
| Centre National de La Recherche Scientifique | 9632 |
14 |
| National Center of Neurology and Psychiatry | 140 |
14 |
| ProQR Therapeutics II B.V. | 102 |
14 |
| Replicor Inc. | 33 |
14 |
| Santaris Pharma A/S | 58 |
14 |
| CuRNA, Inc. | 147 |
13 |
| Arrowhead Pharmaceuticals, Inc. | 216 |
12 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
12 |
| Other owners | 1058 |